Researchers will use this clinical study (V110-911) to learn about the safety and effects of giving a pneumococcal vaccination and COVID-19 booster vaccination at the same visit. This clinical study will help researchers learn:
There are rules in place to help protect the rights, safety, and well-being of people who volunteer for research studies. These rules are put in place to make sure studies follow strict scientific and ethical guidelines. Before a clinical research study can begin, a review board must review the study. This group is called an IRB or institutional review board. An IRB is made up of doctors, scientists, and members of the community.
To participate in the V110-911 study, you must be 50 years or older and:
There are other rules for taking part that the study staff will discuss with you.Get Started
A clinical study is a research study that tries to answer questions about how medicines or vaccines work in the people who take them. Researchers run studies to test whether an investigational medication or vaccine is safe and effective. These studies may help doctors find new ways to help prevent, detect, or treat health problems. Information learned from this clinical research study may help other people in the future. Those participating will receive the following:
Taking part in this study is voluntary and you may stop at any time for any reason. In addition, there is no cost to participants or their insurance for the study drug or study-related care, tests and exams. Reimbursement for time and travel may be provided.
If you would like to see if you are eligible to participate, please find a site near you.Find A Site Near You
If you're interested in learning more about the V110-911 study, including potential risks and benefits of participation, you can find additional details at CTGOV.